Status:
RECRUITING
Efficacy of Treadmill Walking With Hidden Vision for Rehabilitation in the Subacute Phase of Stroke
Lead Sponsor:
Centre Hospitalier Régional Metz-Thionville
Conditions:
Subacute Stroke
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Objective: The aim of this study is to compare the efficiency of vision-obscured versus vision-retained treadmill gait training in subacute post-stroke patients. Methodology: Thirty-six patients with...
Detailed Description
Background: Gait rehabilitation for stroke patients is a major issue in post-stroke functional recovery. The impact of vision on walking and balance is well documented, however, visuo-dependence (the ...
Eligibility Criteria
Inclusion
- 18 years of age or older,
- With a confirmed diagnosis of ischemic or hemorrhagic stroke in sub-acute phase (stroke less than 6 months old),
- With NIHSS scores between 1 and 15 and MoCA scores between 18 and 30
- With a physiotherapy prescription for post Stroke rehabilitation
- Able to walk for 20 min on a treadmill with weight reduction with pauses, able to maintain bipodal balance, able to maintain bipodal balance with eyes open and closed for 30 seconds,
- Having expressed free, informed and written consent
- Affiliated with a social security scheme.
Exclusion
- Patients weighing over 200 kg (maximum weight permitted for use of the Lite Gait ®),
- Patients with impaired vision:
- Best corrected visual acuity below 5/10 on patient examination
- Homonymous lateral hemianopia, quadranopia.
- Inability to physically participate in intensive rehabilitation due to severe, unstabilized and comorbidities (heart, lung, kidney disease or diabetes), severe psychiatric disorders cancer active or under treatment.
- Patients participating in other interventional research,
- Pregnant or breast-feeding women,
- Patients under guardianship.
Key Trial Info
Start Date :
June 4 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 19 2027
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06972355
Start Date
June 4 2025
End Date
July 19 2027
Last Update
October 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHR Metz-Thionville Hopital Legouest
Metz, France, 57085